Tocqueville Asset Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$132K Hold
13,312
– – ﹤0.01% 539
2026
Q2
$108K Buy
13,312
+352
+3% +$2.58K ﹤0.01% 549
2026
Q1
$82.8K Buy
+12,960
New +$83.6K ﹤0.01% 541
2016
Q1
– Sell
-2,650
Closed -$208K – 908
2015
Q4
$208K Sell
2,650
-1,515
-36% -$119K ﹤0.01% 844
2015
Q3
$314K Hold
4,165
– – ﹤0.01% 800
2015
Q2
$486K Sell
4,165
-2,300
-36% -$417K 0.01% 726
2015
Q1
$1.53M Sell
6,465
-500
-7% -$107K 0.02% 516
2014
Q4
$1.32M Sell
6,965
-1,340
-16% -$297K 0.01% 532
2014
Q3
$1.98M Buy
8,305
+6,405
+337% +$1.32M 0.02% 430
2014
Q2
$125K Sell
1,900
-1,500
-44% -$107K ﹤0.01% 1098
2014
Q1
$354K Buy
3,400
+2,100
+162% +$247K ﹤0.01% 656
2013
Q4
$135K Buy
+1,300
New +$76.3K ﹤0.01% 873

Other funds holding PBYI

Tocqueville Asset Management's PBYI Position: Q3 2026 in Review

Tocqueville Asset Management held its Puma Biotechnology (PBYI) position steady in Q3 2026 at 13,312 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Tocqueville Asset Management first reported a position in PBYI in Q4 2013 and has held it in 12 quarters since. The position peaked at $1.98M in Q3 2014. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Tocqueville Asset Management held 13,312 shares of Puma Biotechnology worth $132K as of Q3 2026.
  • Tocqueville Asset Management left its Puma Biotechnology share count unchanged in Q3 2026.
  • Puma Biotechnology made up ﹤0.01% of Tocqueville Asset Management's portfolio in Q3 2026, its #539 holding.
  • Tocqueville Asset Management first reported a position in Puma Biotechnology in Q4 2013 and has held it in 12 quarters since.
  • Tocqueville Asset Management's Puma Biotechnology position peaked at $1.98M in Q3 2014.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Tocqueville Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.